Gene: OSTC
Official Full Name: oligosaccharyltransferase complex non-catalytic subunitprovided by HGNC
Gene Summary: Predicted to contribute to dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Predicted to be involved in protein N-linked glycosylation. Part of oligosaccharyltransferase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15428 | OSTC Knockout cell line (HeLa) | Human | OSTC | 1:3~1:6 | Negative | Online Inquiry |
KO15429 | OSTC Knockout cell line (HCT 116) | Human | OSTC | 1:2~1:4 | Negative | Online Inquiry |
KO15430 | OSTC Knockout cell line (HEK293) | Human | OSTC | 1:3~1:6 | Negative | Online Inquiry |
OSTC Gene Knockout Cell Lines are precision-engineered cellular models designed to facilitate the functional analysis of gene expression and the study of gene-related diseases. Each knockout line features a specific gene disabled through CRISPR-Cas9 technology, enabling researchers to discern the roles of targeted genes in various biological processes. By silencing particular genes, these cell lines provide a robust platform for examining the effects on cellular behavior, signaling pathways, and metabolic functions, thus allowing for the investigation of gene function and interaction in a controlled environment.
The key mechanism underlying OSTC Gene Knockout Cell Lines lies in the highly efficient CRISPR-Cas9 gene-editing technology, which introduces double-strand breaks at precise genomic locations. Consequently, the natural DNA repair processes fail to restore these genes, effectively inactivating them. This method not only ensures high specificity and efficacy but also promotes the generation of cells that closely mimic disease states or reveal therapeutic targets, ultimately accelerating the pace of biomedical research.
The scientific importance of these cell lines is particularly pronounced in academic and clinical settings where understanding gene function is crucial for drug discovery, development of gene therapies, and elucidating the molecular basis of diseases. For instance, these knockout cell lines can significantly aid in cancer research, allowing for the dissection of tumor suppressor genes and oncogenes.
Compared to other gene-editing approaches, OSTC Gene Knockout Cell Lines offer unparalleled reliability, user-friendly protocols, and broader application potentials across various fields such as pharmacology, toxicology, and regenerative medicine. Their ease of use minimizes labor-intensive steps commonly associated with traditional knockout techniques, thereby streamlining workflows and enhancing productivity.
These products represent invaluable tools for researchers and clinicians seeking to unlock the complexity of genetic contributions to health and disease. By providing high-quality, reproducible models that address specific research questions, OSTC Gene Knockout Cell Lines empower scientists to make groundbreaking discoveries that advance our understanding of biology.
With years of expertise in cutting-edge gene-editing technologies and a commitment to delivering innovative solutions, our company ensures that OSCT Gene Knockout Cell Lines meet the highest standards of quality and performance, enabling researchers to achieve meaningful results in their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.